Neuroprotective effect of cycloheximide on hypoxic-ischemic brain injury in neonatal rats. 2006

Won Soon Park, and Dong Kyung Sung, and Saem Kang, and Soo Hyun Koo, and Yu Jin Kim, and Jang Hoon Lee, and Yun Sil Chang, and Munhyang Lee
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Korea.

This study was done to determine the neuroprotective effect of cycloheximide on neonatal hypoxic-ischemic brain injury. Seven day-old newborn rat pups were subjected to 90 min of 8% oxygen following a unilateral carotid artery ligation. The extent of cerebral infarction was evaluated at 1 and 4 week of recovery. Apoptosis was identified by performing terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining and flow cytometry with a combination of fluoresceinated annexin V and propidium iodide. Brain infarction area was significantly increased at 4 week compared to 1 week after hypoxia-ischemia in the control group. With cycloheximide treatment, the number of TUNEL positive cells in the ipsilateral cerebral cortex at 48 hr and peri-infarct area at 1 and 4 week of recovery was significantly reduced, both apoptotic and necrotic cells by flow cytometry 48 hr after the injury were significantly reduced, and the extent of cerebral infarction at 1 and 4 week of recovery was also significantly attenuated compared to the hypoxia-ischemia control group. In summary, our data suggest that apoptosis plays an important role in the development of delayed infarction, and inhibition of apoptosis with cycloheximide significantly reduces the ensuing cerebral infarction in a newborn rat pup model of cerebral hypoxia-ischemia.

UI MeSH Term Description Entries
D011419 Propidium Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits. Propidium Diiodide,Propidium Iodide,Diiodide, Propidium,Iodide, Propidium
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017304 Annexin A5 A protein of the annexin family isolated from human PLACENTA and other tissues. It inhibits cytosolic PHOSPHOLIPASE A2, and displays anticoagulant activity. Annexin V,Placental Anticoagulant Protein I,Anchorin CII,Calphobindin I,Endonexin II,Lipocortin V,Lipocortin-V
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018696 Neuroprotective Agents Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. Neuroprotectant,Neuroprotective Agent,Neuroprotective Drug,Neuroprotectants,Neuroprotective Drugs,Neuroprotective Effect,Neuroprotective Effects,Agent, Neuroprotective,Agents, Neuroprotective,Drug, Neuroprotective,Drugs, Neuroprotective,Effect, Neuroprotective,Effects, Neuroprotective

Related Publications

Won Soon Park, and Dong Kyung Sung, and Saem Kang, and Soo Hyun Koo, and Yu Jin Kim, and Jang Hoon Lee, and Yun Sil Chang, and Munhyang Lee
April 2017, Journal of clinical neurology (Seoul, Korea),
Won Soon Park, and Dong Kyung Sung, and Saem Kang, and Soo Hyun Koo, and Yu Jin Kim, and Jang Hoon Lee, and Yun Sil Chang, and Munhyang Lee
January 2003, Biology of the neonate,
Won Soon Park, and Dong Kyung Sung, and Saem Kang, and Soo Hyun Koo, and Yu Jin Kim, and Jang Hoon Lee, and Yun Sil Chang, and Munhyang Lee
June 2014, Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery,
Won Soon Park, and Dong Kyung Sung, and Saem Kang, and Soo Hyun Koo, and Yu Jin Kim, and Jang Hoon Lee, and Yun Sil Chang, and Munhyang Lee
October 2006, Experimental neurology,
Won Soon Park, and Dong Kyung Sung, and Saem Kang, and Soo Hyun Koo, and Yu Jin Kim, and Jang Hoon Lee, and Yun Sil Chang, and Munhyang Lee
January 2013, Brain & development,
Won Soon Park, and Dong Kyung Sung, and Saem Kang, and Soo Hyun Koo, and Yu Jin Kim, and Jang Hoon Lee, and Yun Sil Chang, and Munhyang Lee
October 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Won Soon Park, and Dong Kyung Sung, and Saem Kang, and Soo Hyun Koo, and Yu Jin Kim, and Jang Hoon Lee, and Yun Sil Chang, and Munhyang Lee
August 2007, Early human development,
Won Soon Park, and Dong Kyung Sung, and Saem Kang, and Soo Hyun Koo, and Yu Jin Kim, and Jang Hoon Lee, and Yun Sil Chang, and Munhyang Lee
January 2016, Bratislavske lekarske listy,
Won Soon Park, and Dong Kyung Sung, and Saem Kang, and Soo Hyun Koo, and Yu Jin Kim, and Jang Hoon Lee, and Yun Sil Chang, and Munhyang Lee
November 2017, Neurochemical research,
Won Soon Park, and Dong Kyung Sung, and Saem Kang, and Soo Hyun Koo, and Yu Jin Kim, and Jang Hoon Lee, and Yun Sil Chang, and Munhyang Lee
November 2015, Drug discovery today,
Copied contents to your clipboard!